Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 20;109(6):1540–1549. doi: 10.1210/clinem/dgad749

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — The proportion of liver histological features in patients with MAFLD with or without MHF in the PERSONS cohort. The proportion of (A) steatosis, (B) ballooning, (C) lobular inflammation, (D) significant fibrosis, (E) advanced fibrosis, and (F) hepatocellular iron deposition in MHF and non-MHF. The data in the percentage column chart are the numbers (percentage, %). The P values are P for trend: *P trend < .05; **P trend < .005; ***P trend < .001. Abbreviations: MHF, metabolic hyperferritinaemia; MAFLD, metabolic dysfunction-associated fatty liver disease.